SIGLEC6
Sialic acid-binding Ig-like lectin 6
Also known as: CD327, CD33L, CD33L1, OB-BP1, SIGL6_HUMAN, SIGLEC-6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43699
- Gene
- SIGLEC6
- Ensembl
- ENSG00000105492
- Chromosome
- 19
- Canonical length
- 453 aa
- Protein class
- CD markers, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the SIGLEC (sialic acid binding immunoglobulin-like lectin) family of proteins. The encoded transmembrane receptor binds sialyl-TN glycans and leptin. Placental expression of the encoded protein is upregulated in preeclampsia. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
453 residues, UniProt reviewed canonical sequence.
>O43699|SIGLEC6
1 MQGAQEASAS EMLPLLLPLL WAGALAQERR FQLEGPESLT VQEGLCVLVP CRLPTTLPAS
61 YYGYGYWFLE GADVPVATND PDEEVQEETR GRFHLLWDPR RKNCSLSIRD ARRRDNAAYF
121 FRLKSKWMKY GYTSSKLSVR VMALTHRPNI SIPGTLESGH PSNLTCSVPW VCEQGTPPIF
181 SWMSAAPTSL GPRTTQSSVL TITPRPQDHS TNLTCQVTFP GAGVTMERTI QLNVSYAPQK
241 VAISIFQGNS AAFKILQNTS SLPVLEGQAL RLLCDADGNP PAHLSWFQGF PALNATPISN
301 TGVLELPQVG SAEEGDFTCR AQHPLGSLQI SLSLFVHWKP EGRAGGVLGA VWGASITTLV
361 FLCVCFIFRV KTRRKKAAQP VQNTDDVNPV MVSGSRGHQH QFQTGIVSDH PAEAGPISED
421 EQELHYAVLH FHKVQPQEPK VTDTEYSEIK IHKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIGLEC6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- placenta: 100 nTPM
- lung: 4.2 nTPM
- tonsil: 4 nTPM
- lymph node: 3.6 nTPM
- small intestine: 3.4 nTPM
- rectum: 2.9 nTPM
Single-cell type
- syncytiotrophoblasts: 428 nCPM
- migrating cytotrophoblasts: 228 nCPM
- cytotrophoblasts: 204 nCPM
- mast cells: 198 nCPM
- pdcs: 16 nCPM
- b-cells: 6.2 nCPM
Immune cell
- plasmacytoid DC: 11 nTPM
- memory B-cell: 7.2 nTPM
- basophil: 4.9 nTPM
- naive B-cell: 4.5 nTPM
- myeloid DC: 1.7 nTPM
- NK-cell: 0.8 nTPM
Brain region
- white matter: 2.2 nTPM
- basal ganglia: 2.1 nTPM
- cerebellum: 2.1 nTPM
- cerebral cortex: 2 nTPM
- amygdala: 1.8 nTPM
- choroid plexus: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin V-set domain
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Sialic acid-binding Ig-like lectin
- Immunoglobulin domain
- Immunoglobulin I-set domain
- Immunoglobulin V-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIGLEC6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIGLEC6 as an antibody target. Whether an autoantibody or antibody against SIGLEC6 could matter depends on whether native SIGLEC6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIGLEC6 is annotated at the cell surface, where native SIGLEC6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIGLEC6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...